Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges
What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s largest health care companies. They discuss…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from In Good Company with Nicolai Tangen
See all episodes →
43%Venki Ramakrishnan: The Science and Hype of Living Longer
41%Eliot Higgins: How Bellingcat Hunts Down the Truth
39%Horizon Robotics CEO: Car Chips, Mind-Off Driving and China's Speed
Similar episodes from other shows
More like In Good Company with Nicolai Tangen →
Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company
Andreessen Horowitz's Vijay Pande: "AI doctors"
Longevity: Can We Add Another 30 Years? | The Decade Ahead
The $2 Trillion Mind | Nicolai Tangen
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.